Welcome to our dedicated page for xspa news (Ticker: xspa), a resource for investors and traders seeking the latest updates and insights on xspa stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect xspa's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of xspa's position in the market.
XpresSpa Group announced the launch of its XpresCheck™ COVID-19 testing facilities at Dulles International Airport and Reagan National Airport, expected to commence operations by mid-March. The Dulles facility will have nine testing rooms, allowing for over 500 tests daily, while the Reagan location will feature four rooms, accommodating over 300 tests. This expansion supports safe air travel and enhances testing options, including Rapid Molecular and PCR tests.
XpresSpa Group, Inc. (XSPA) announced the opening of its second XpresCheck COVID-19 testing facility at Newark Liberty International Airport in collaboration with United Airlines. The new facility, located in Terminal C, features four testing rooms and can administer over 300 tests per day, increasing total testing capacity at the airport to 800. This expansion aims to enhance travel safety and support United Airlines' commitment to providing accessible testing options for its customers.
XpresSpa Group, Inc. (Nasdaq: XSPA) has announced the construction of two new XpresCheck testing facilities at Houston's George Bush Intercontinental Airport and Newark Liberty International Airport. The Houston facility, located in United Terminal E, will open in early March and handle over 300 tests daily, while Newark's facility in Terminal C aims to open mid-February. Both facilities will offer Rapid Molecular and PCR COVID-19 testing. This partnership with United Airlines enhances travel safety and convenience during increasing passenger demand.
XpresSpa Group, Inc. (Nasdaq: XSPA) has announced the launch of an XpresCheck™ COVID-19 testing facility at Salt Lake City International Airport, designed to test over 300 individuals daily. Offering both Rapid Molecular and PCR Tests, the facility will cater to airline passengers and airport staff, ensuring all insurance plans are accepted. CEO Doug Satzman emphasized the importance of this initiative amidst rising COVID-19 cases, aiming to enhance safety for travelers and employees. This facility marks a significant step in XpresSpa's ongoing response to public health demands.
XpresCheck, a subsidiary of XpresSpa Group, has partnered with Hawaiian Airlines to provide on-site COVID-19 testing for passengers at John F. Kennedy International Airport, Boston Logan International Airport, and Phoenix Sky Harbor Airport. This initiative allows travelers on non-stop flights to Hawai‘i to bypass the state's 10-day quarantine by taking a $200 rapid test. Passengers receive results while they wait, enhancing travel safety and convenience. This partnership aims to restore confidence in travel during the pandemic.
XpresSpa Group (Nasdaq: XSPA) announced a lease amendment for a new XpresCheck COVID-19 testing facility at Salt Lake City International Airport, expected to start operations by mid-January. This facility will feature four testing rooms and can conduct over 250 tests daily, including Rapid Molecular and PCR tests. CEO Doug Satzman emphasized the importance of efficient testing for travelers and the company's goal to lead in the travel health sector. The pop-up model allows for quicker, cost-effective expansion of services to more airports.
XpresSpa Group (Nasdaq: XSPA) announced the construction of a new XpresCheck testing facility at Logan International Airport, set to open in early January 2021. This location, situated in JetBlue’s Terminal C, will provide rapid and PCR COVID-19 tests for travelers. The partnership aims to enhance safety for passengers amid Massachusetts' testing requirements for returning travelers, allowing them to access testing conveniently upon arrival. The initiative is part of XpresSpa's broader strategy to expand its COVID-19 testing services nationally.
XpresSpa Group, Inc. (Nasdaq: XSPA) has announced a registered direct offering of 24,509,806 shares of common stock and short-term warrants to purchase an equal number of shares, priced at $1.70 each. The gross proceeds are estimated at $41.66 million, intended for new locations, working capital, and general corporate purposes. The offering is expected to close on December 21, 2020, subject to standard conditions. H.C. Wainwright & Co. is the exclusive placement agent for this transaction.
XpresCheck, a subsidiary of XpresSpa Group (Nasdaq: XSPA), has partnered with United Airlines to offer COVID-19 testing services at Newark Liberty and Denver International Airports starting December 21, 2020. This initiative aims to facilitate safer travel by enabling rapid molecular testing for passengers on select flights to Hawaii. Travelers testing positive will be required to self-isolate. XpresCheck’s services aim to restore traveler confidence as more destinations adopt testing requirements amid the COVID-19 pandemic.
XpresSpa Group has opened a new XpresCheck™ COVID-19 testing facility at Denver International Airport as of December 16, 2020. This pop-up location is situated in Concourse B and features six testing rooms, with an estimated capacity of over 400 tests per day. Testing options include Rapid Molecular and PCR tests, available to all passengers and airport employees. The facility accepts various insurance plans while ensuring HIPAA compliance. This marks the company's fifth testing site and introduces a cost-effective modular approach for future rollouts.
FAQ
What is the market cap of xspa (xspa)?
